Cure SMA India Foundation, associated with Cure SMA India, filed a petition in the Supreme Court alleging that comedian Samay Raina and others made insensitive remarks targeting persons with disabilities by mocking the high costs of treatment for Spinal Muscular Atrophy (SMA). The petition calls for both remedial and punitive measures to guard against hate speech and to protect marginalized groups.

Cure SMA India, through its affiliated Cure SMA Foundation, has approached the Supreme Court to challenge insensitive remarks made by comedian Samay Raina concerning treatments for Spinal Muscular Atrophy and derogatory comments about persons with disabilities. The plea demands that the court implead all responsible parties and consider measures to protect the dignity and rights of disabled individuals.

Cure SMA Foundation, a branch of the global organization aligned with Cure SMA India, filed a petition in the Supreme Court urging legal action against hate speech and derogatory remarks targeting persons with disabilities. This move aims to protect marginalized communities and uphold respect for human dignity.

Cure SMA India, through its parent organization Cure SMA Foundation of India, has expressed strong support for the Government of India’s unprecedented allocation of over Rs 900 Crore towards rare disease treatments, including SMA. The organization urged the government to expedite the centralized procurement process as directed by the court, emphasizing the critical need for timely access to life-saving treatments for SMA patients.

Cure SMA Foundation of India, a leading patient advocacy organization for SMA, has expressed its appreciation for the Government of India's historic allocation of over ₹900 crore towards rare disease treatment, including SMA. The organization urged the government to implement the centralized procurement process within 45 days, signaling strong support for progressive healthcare policies and collaborative stakeholder efforts.

Cure SMA India, through the Cure SMA Foundation, acknowledged the allocation of over Rs 900 crore by the Government of India and the Delhi High Court for rare disease treatments, including SMA. The foundation expressed gratitude towards key governmental figures and called for the expedited initiation of a procurement process to ensure timely access to life-saving treatments.

Cure SMA India, through a virtual press conference, urged the government to allocate the ₹974 crore national fund for rare diseases as mandated by a Delhi High Court order, highlighting the urgent need for improved, multidisciplinary care for SMA patients.

The Supreme Court summoned social media influencers after a petition from Cure SMA Foundation of India, an affiliate of Cure SMA India, alleged that the influencers mocked individuals with Spinal Muscular Atrophy (SMA). The move is aimed at enforcing respectful discourse and legal protection for disabled persons.